2019.10.11
2019.10.11
Citrine Medicine Founded
2020.07.13
2020.07.13
Citrine Medicine, A Rare Disease Platform Company Focused On The China Market, Launches After Raising $80 Million In Series A Funding
2020.10.28
2020.10.28
Citrine Medicine Advances Efforts To Create The Very First Rare Disease Ecosystem In China Through Strategic Partnership With Bioprojet To License Exclusive Rights For The Use Of Orphan Narcolepsy Therapy Wakix® (Pitolisant)
2021.02.05
2021.02.05
Zircon Health Founded
2021.03.21
2021.03.21
Citrine Medicine Announces Strategic Partnership To Bring Alkindi® To China For Use In Pediatric Congenital Adrenal Hyperplasia (CAH)
2021.03.21
2021.03.21
RareStone Group And CHARD（China Alliance for Rare Disease） Announce Strategic Partnership to Build Eco-system of Rare Disease For Patients and Their Families.
2021.03.29
2021.03.29
Citrine Medicine And Sinopharm Group Announce Strategic Partnership To Broaden And Accelerate Access To Rare Disease Drugs In China